Search results
Results from the WOW.Com Content Network
Viagra is definitely not an appropriate first-line treatment for Raynaud’s phenomenon, but in situations where more common medications have failed, it could be an option. Halfpoint/istockphoto ...
Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. [4] [8] It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. [9] It is unclear if it is effective for treating sexual dysfunction in females. [8]
The medicalisation of sexuality has also been used to advance the pharmaceutical industry through treatments for erectile dysfunction and female sexual dysfunction. Another key influence of the medicalisation of sexuality is social control, mass surveillance and regulation related to risk profiling for medicalised sexual disorders. [2]
PDE5 inhibitors have been used as a second line therapy in severe cases of Raynaud phenomenon when it is related to systemic sclerosis per The European Society for Vascular Medicine guidelines. [ 3 ] Sildenafil, the prototypical PDE5 inhibitor, was originally discovered during the search of a novel treatment for angina .
Viagra’s main ingredient sildenafil is part of a class of drugs referred to as PDE5 inhibitors, which (unlike non-prescription supplements) are approved by the FDA for the treatment of ED.
Viagra was approved by the FDA as a treatment for ED in 1998. It’s now sold as brand name Viagra and as generic sildenafil. It takes around 30 to 60 minutes for a normal dose of Viagra to begin ...
Treatment approach is dependent on the type of dysfunction the women is experiencing. [21] The treatment of female sexual dysfunction is varied as multiple causes are often identified. Following evaluation of symptoms and diagnosis, the woman's goals for treatment are determined and used to track progress.
Viagra gets better funding than women’s health, says Laura Bates. Jessie Thompson. May 26, 2024 at 9:06 AM. ... The first UK inquiry into birth trauma was published last week, with its authors ...